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INTRODUCTION
Human immunodeficiency virus (HIV)-the etiologic agent of acquired immunodeficiency syndrome (AIDS)-is the fastest growing cause of death in women of reproductive age [1] [2] [3] .
Worldwide, heterosexual transmission accounts for 90% of all HIV infections in women [2, 4] . Currently, an estimated 14.1 million women worldwide are infected with HIV, representing 44% of all adult infections. Considering that the AIDS pandemic is still in its infancy on a global scale, this evolving demographic situation warrants urgent attention, particularly for the adolescent population. Therefore, effective strategies are needed to reduce heterosexual and perinatal HIV transmission. In the absence of an effective prophylactic anti-HIV therapy or vaccine, new emphasis has been placed on the development of intravaginal microbicidal agents capable of reducing the transmission of HIV [5, 6] . In addition, prophylactic contraception is fundamentally important in HIV-infected women for prevention of HIV transmission and pregnancy, especially because 80% of women with AIDS are of childbearing age [7] .
At present, all commercially available spermicidal microbicides have detergent ingredients that disrupt cell membranes [8, 9] . The most widely used vaginal spermicide, nonoxynol-9 (N-9) has been shown because of its membrane-disruptive properties to damage the cervicovaginal epithelium [10] [11] [12] , cause an acute inflammatory tissue response [13] , alter vaginal microflora [14, 15] , and enhance the risk of promoting opportunistic infections in the genitourinary tract [16] . Such opportunistic infections are known to enhance the susceptibility of the ectocervical epithelium and the endocervical mucosa to HIV infection [17] [18] [19] . Despite its ability to inactivate HIV in vitro, the reported failure of N-9 to prevent heterosexual vaginal transmission of HIV in clinical settings in addition to its adverse effects on the cervicovaginal epithelium and vaginal microflora has prompted the search for new femalecontrolled microbicides that are both more effective and safer than N-9 [20] [21] [22] [23] [24] . Unlike the detergent-based microbicides that target cell membranes, the intravaginal or intrarectal use of topical formulations of anti-HIV drugs such as nonnucleoside inhibitors (NNIs) might be an effective approach for preventing the sexual transmission of HIV. These inhibitors of viral replication have been proposed by the World Health Organization as candidates for intravaginal microbicides to inhibit HIV replication in mucosal cells [25, 26] . Inasmuch as physiological fertilization is dependent on the ability of ejaculated sperm to swim, bind the zona pellucida, and penetrate the egg, all of which are primarily dependent on sperm motility, adding spermicidal function to potent anti-HIV drugs could be an effective way to curb heterosexual HIV transmission as well as prevent conception.
Design of potent inhibitors of HIV-1 reverse transcriptase (RT) has been a focal point in translational AIDS research [27] [28] [29] [30] . The NNIs are a diverse set of compounds that include tetrahydroimidazobenzodiazepinethione, also known as TIBO, compounds [31] ; 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine, also known as HEPT, derivatives [32] [33] [34] [35] ; bis(heteroaryl)piperazine, also known as BHAP, analogues [30] ; 2Ј-5Ј-bis-O-(tertbutyldimethylsilyl)-3Ј-spiro-5ЈЈ-(4ЈЈ-amino-1ЈЈ, 2ЈЈ-oxathiole-2ЈЈ, 2ЈЈ-dioxide) pyrimidine, also known as TSAO [36] ; dihydroalkoxybenzyloxopyrimidine, also known as DABO [37, 38] ; and phenethylthiazolylthiourea, also known as PETT, derivatives [39] [40] [41] [42] . They interfere with the activity of viral RT by binding to a specific allosteric site of HIV-1 RT near the polymerase site and severely limit the conformational flexibility needed for its function, rendering the viral protein inactive [43] [44] [45] [46] [47] [48] [49] . A number of crystal structures of RT complexed with NNIs have been reported, and such structural information has provided the basis for further derivatization of NNI aimed at maximizing binding affinity to RT [44] [45] [46] [47] [48] [49] [50] .
The success of NNIs for the clinical treatment of AIDS has led us to the computer-aided design and chemical synthesis of mechanism-based antiretroviral agents that also exhibit spermicidal activity. Recently, we described the structure-based design and synthesis of novel NNIs by generating a novel computer model in which a composite binding pocket was constructed from nine individual crystal structures of RT-NNIs complexes [51, 52] . This computerdocking procedure revealed abundant sterically allowed usable space surrounding the pyridyl ring of the thiourea compound, trovirdine. Therefore, we strategically designed functional groups to obtain more potent anti-HIV agents with higher affinity for the NNI-binding pocket of HIV-1 RT that also exhibit spermicidal activity [53] . In an attempt to gain further insight into the structural determinants controlling these two properties, we have synthesized 30 novel thiourea compounds and examined them for anti-HIV activity as well as for spermicidal activity. Here, we report the identification of several dual-function thiourea compounds with potent anti-HIV activity and sperm-immobilizing activity (SIA). The discovery of the potent dual-function properties of phenyl-and cyclohexenyl-substituted thiourea compounds is particularly relevant for curbing vaginal transmission of HIV by leukocytes and sperm as the infectious cells in the semen [54, 55] .
MATERIALS AND METHODS

Reagents and Instrumentation
All chemicals were purchased from Aldrich Chemical Corporation (Milwaukee, WI). Anhydrous acetonitrile and N,N-dimethylformamide were transferred to reaction vessels via cannula under nitrogen. All reactions were carried out under nitrogen. Proton ( 1 H), carbon ( 13 C), and fluorine ( 19 F) nuclear magnetic resonance spectra (NMR) were recorded on a Varian Oxford 300-MHz spectrometer (Varian Associates, Palo Alto, CA) using an automated broadband probe. All NMR spectra were recorded in CDCl 3 . 13 C NMR spectra were recorded using the proton-decoupling technique. 19 F NMR spectra were recorded in CDCl 3 , and a 1% solution of trifluoroacetic acid in water was used as an internal standard in a fused capillary tube. Fourier transform infrared (FT-IR) spectra were recorded with a FT-Nicolet Model Protege 460 instrument (Nicolet Instrument Corp., Madison, WI). Mass spectra analyses were performed by using a model G2025A Hewlett Packard (Wilmington, DE) matrix-assisted laser desorption spectrometer in the molecular ion detection mode. The matrix used was cyanohydroxycinnamic acid. Ultraviolet (UV) spectra were recorded from Beckmann model 3DU 7400 UV-Visible spectrophotometer (Beckmann Instruments, Fullerton, CA) using a cell-path length of 1 cm. Elemental analysis was performed by MicroLab Inc. (Atlanta, GA). Column chromatography was performed using silica gel. The solvents used for elution varied depending on the compound and included one of the following: ethyl acetate, methanol, chloroform, hexane, methylene chloride, and ether.
Synthetic Scheme for Substituted Thiourea Derivatives
The names of the 31 thiourea compounds synthesized and tested in this study are listed in Table 1 . The synthesis of 30 novel thiourea compounds as inhibitors of HIV-1 RT was based on a computer model in which a composite binding pocket was constructed from 9 individual crystal structures of RT-NNI complexes [51, 52] . Modeling studies for rational drug design included the construction of a composite NNI-binding pocket for nine RT-NNI crystal structures, the analyses of surface complementarity between NNIs and RT, and application of inhibitory constants (K i values) combined with a docking procedure involving the novel thiourea compounds [51, 52] . Our computational approach allowed the identification of several ligand derivatization sites for the generation of more potent dual-function thiourea compounds. Our detailed analysis of trovirdine [51] revealed multiple sites that can be used for the incorporation of larger functional groups. In our composite binding pocket, the docked trovirdine molecule showed abundant sterically allowed usable space surrounding the pyridyl ring and the ethyl linker and near the 5Ј-bromo position. We hypothesized that addition of strategically designed functional groups should yield more potent anti-HIV agents with SIA. Therefore, we synthesized a series of thiourea compounds in which one of the nitrogen atoms of the thiourea was attached to a phenyl, heterocyclic, or alicyclic moiety through a ethyl bridge, and the other nitrogen atom was attached to a 5Ј-bromo-or 5Ј-trifluoromethyl-substituted or an unsubstituted pyridyl ring.
For the synthesis of novel 5Ј-substituted pyridyl thiourea compounds, additional substitutions on the phenyl ring included either fluoro, chloro, bromo or methoxy groups at ortho (2, 5) , meta (3), or para (4) positions on the phenyl ring. Figure 1 shows the general synthetic scheme followed as detailed in previous reports [51, 52, 56, 57] . Trovirdine (N-[2-(pyridyl)]-NЈ-[2-5-bromopyridinyl)-thiourea) was synthesized according to literature procedure [42] .
Determination of the Partition Coefficients (P a )
The partition of the test compounds between n-octanol and water as a measure of their lipophilicity was determined by taking the UV absorption of each compound in n-octanol, water-saturated n-octanol (1:1), and n-octanolsaturated water (1:1). The UV absorption maxima were determined by selecting a wavelength with the maximum absorption peak in the water-saturated octanol layer and the corresponding peak in the octanol-saturated water. Three absorption spectra were obtained for each compound. The partition coefficient (P a ) was calculated as the ratio of the compound concentration present in the lipid phase to the compound concentration present in the aqueous phase.
In Vitro Assays of Anti-HIV Activity
The HTLV IIIB strain of HIV-1 was propagated in CCRF-CEM cells, and the virus stocks obtained from cell-free supernatants of infected cells were titered using MT-2 cells [58, 59] . Cell-free supernatants were harvested and frozen in 1-ml aliquots at Ϫ70ЊC. Titration of the stock virus was performed using MT-2 cells, and the cytopathic effect of the virus used in this study was typical of HIV-1 on MT-2 cells [58, 59] .
For in vitro assays of the anti-HIV-1 activities of phenyl, heterocyclic, and alicyclic ring-substituted thiourea compounds, normal peripheral blood mononuclear cells 
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Synthetic scheme for phenyl, heterocyclic, and alicyclic ringcontaining substituted thiourea compounds.
(PBMCs) from HIV-1 negative donors were cultured for 72 h in RPMI 1640 medium (Gibco-BRL, Grand Island, NY) with 20% (v/v) heat-inactivated fetal calf serum, 3% interleukin 2, 2 mM L-glutamine, 25 mM Hepes, 2 g/L Na-HCO 3 , 50 g/ml gentamicin, and 4 g/ml phytohemagglutinin prior to exposure to HIV-1 at a multiplicity of infection of 0.1 during a 1-h adsorption period at 37ЊC in a humidified 5% CO 2 atmosphere. Stock solutions (10 mM) of thiourea compounds were prepared in dimethylsulfoxide (DMSO). Cells were cultured for 7 days in 96-well microtiter plates (100 l/well; 2 ϫ 10 6 cells per milliliter, triplicate wells) in the presence and absence of various concentrations (0.001 to 100 M) of the thioureas. Cells from noninfected controls were handled in the same way, except the virus was omitted from the preparation. Aliquots of culture supernatants were removed from the wells on the seventh day after infection for p24 antigen, as previously described [59, 60] . The p24 enzyme immunoassay was the unmodified kinetic assay available commercially (Coulter Corporation/Immunotech, Inc., Westbrook, ME). The assay uses a murine monoclonal antibody to the HIV core protein, coated onto microwell strips to which the antigen present in the test culture supernatant sample binds [56] [57] [58] . The plates were read on an ELISA reader (Molecular Devices, Sunnyvale, CA) at 650 nm, and p24 levels, expressed in nanograms per milliliter, were calculated against known standards supplied by Coulter/Immunotech, Inc. Percentage viral inhibition was calculated by comparing the p24 values for the test substance-treated infected cells with the p24 values for untreated, infected cells (i.e., virus controls). Each of the 31 thiourea compounds was tested for RT inhibitory activity against purified, recombinant HIV-1 RT by the cell-free Quan-T-RT system (Amersham Corp., Arlington Heights, IL), which utilizes the scintillation proximity assay principle [61] . The anti-HIV activity was expressed as the IC 50 value, calculated from the dose-response curves, and defined as the drug concentration that decreases p24 antigen production in HIV-1-infected PBMCs or the HIV-1 rRT activity by 50%.
Assays of SIA
To evaluate the effect of each of the 31 thiourea compounds on human sperm motility and kinematics, highly motile fractions of sperm were prepared from donor semen (n ϭ 8) by discontinuous (90-45%) gradient centrifugation using Enhance Plus medium (Conception Technologies, San Diego, CA) and the swim-up method [53, 62] . The swim-up method was used after density gradient centrifugation, washing, and resuspension of sperm in Biggers, Whitten, and Whittingham medium (BWW)-3% BSA. Pooled swim-up fraction was washed once prior to spermicidal assay. All donor semen specimens were obtained after informed consent and in compliance with the guidelines of the Parker Hughes Institute Institutional Review Board. Pooled motile sperm (Ն10 ϫ 10 6 per milliliter) prepared from three to six donors were suspended in 1 ml of BWW containing 25 mM Hepes (Irvine Scientific, Santa Ana, CA), and 0.3% BSA in the presence and absence of serial twofold dilutions of test substance (500 to 15.6 M) in 0.5% DMSO. The stock solutions of thioureas were prepared in DMSO (100 mM) and diluted in assay medium to yield the desired concentrations (up to 1000 M). Corresponding volume of DMSO (either 0.5% or 1%) was added to control tubes. After 3 h incubation at 37ЊC, the percentage of motile sperm was evaluated by CASA [53, [62] [63] [64] . The motility percentages were compared with those in sham-treated control suspensions of motile sperm. The SIA of the compounds was expressed as the mean EC 50 values (the final concentration of the compound in medium that decreases the proportion of motile sperm by 50%), calculated from three independent experiments.
Sperm Kinematic Parameters
For computer-assisted sperm analysis (CASA), 5 l of each sperm suspension was loaded into a 20-m Microcell slide (Conception Technologies) in a counting chamber at 37ЊC. At least five to eight fields per slide were scanned for analysis using a Hamilton Thorne Integrated Visual Optical System, version 10, instrument (Hamilton Thorne Research Inc., Danvers, MA). Each field was recorded for 30 sec. The computer calibrations were set at 30 frames at a frame rate of 30 per second. Other settings were as follows: minimum contrast, 8; minimum size, 6; low-size gate, 1.0; high-size gate, 2.9; low-intensity gate, 0.6; high-intensity gate, 1.4; phase-contrast illumination; low path velocity at 10 m/sec; and threshold straightness at 80%; and magnification factor, 1.95.
The sperm kinematics parameters that were determined included numbers of motile and progressively motile sperm; curvilinear velocity (VCL; a measure of the total distance traveled by a given sperm during the acquisition divided by the time elapsed); average path velocity (VAP; the spatially averaged path that eliminates the wobble of the sperm head), straight-line velocity (VSL; the straightline distance from beginning to end of track divided by time taken), beat-cross frequency (BCF; frequency of sperm head crossing sperm average path), the amplitude of lateral sperm-head displacement (ALH; the mean width of sperm head oscillation), and the derivatives straightness (STR ϭ VSL/VAP ϫ 100) and linearity (LIN ϭ VSL/VCL ϫ 100; departure of sperm track from a straight line). Data from each individual cell track were recorded and analyzed. At least 200 motile sperm were analyzed for each aliquot sampled.
Assay for Cell Viability
The potential cytotoxicity of two phenyl ring-(HI-240 and HI-253), one heterocyclic ring-(HI-207) and two cyclohexenyl (HI-346 and 445) ring-containing, most potent dual-function thiourea compounds, in comparison to N-9, against normal human vaginal, ectocervical, and endocervical epithelial cells (Clonetics Corporation, San Diego, CA), was measured by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide)-based assay [53, 65] . Briefly, exponentially growing vaginal, ectocervical, and endocervical epithelial cells were seeded into 96-well plates at a density of 2 ϫ 10 4 cells per well and incubated for 24 h at 37ЊC prior to drug exposure. On the day of treatment, culture medium was aspirated from the wells and replaced with fresh medium containing serial twofold drug concentrations ranging from 7.8 to 1000 M. N-9 (IGEPAL CO-630; Rhone-Poulenc, Cranbury, NJ) was diluted in PBS. Triplicate wells were used for each treatment. Culture plates were then incubated for 3 h before adding 10 l of MTT solution (5 mg/ml in PBS) to each well. Wells containing only medium and MTT were used as control for each plate. The tetrazolium/formazan reaction was allowed to proceed for 4 h at 37ЊC, and then 100 l of the solubilization buffer (10% sodium dodecyl sulfate in 0.1% HCl) was added to all wells and mixed thoroughly to dissolve the dark-blue formazan crystals. After an overnight incubation at 37ЊC, the optical density at 540 nm were measured with a 96-well multiscanner autoreader, with the solubilization buffer serving as blank. To translate the OD 540 values into the number of live cells in each well, the OD 540 values were compared with those of standard OD 540 -versus-cell number curves generated for each cell line. The percentage survival was calculated using the following formula: % survival ϭ live cell number in test group/live cell number in control group ϫ 100. The results were expressed as mean IC 50 values for three independent experiments. The IC 50 [MTT] was defined as the concentration required for 50% reduction in cell survival.
Statistical Analysis
Results are presented as the mean or as mean Ϯ SD values from independent measurements. Nonlinear regression analysis was used to find IC 50 and EC 50 values from the concentration-effect curves using the PRISM, version 2.0, software program (GraphPad, San Diego, CA).
RESULTS
Anti-HIV and SIA of Phenyl Thiourea Compounds
Thiourea compounds were assayed for their ability to inhibit HIV-1 replication in normal human PBMCs infected with the HIV-1 strain HTLV IIIB (reported as IC 50 [p24]), as well as for their RT-inhibitory activity in cell-free assays using purified recombinant HIV-1 RT (reported as IC 50 [rRT]). The SIA of thiourea compounds was evaluated by CASA (reported as EC 50 ). The lipophilicity of the compounds was measured by their partition coefficients between n-octanol and water (reported as P a ).
We tested the effect of ring substitution and functionalization of the pyridyl moiety of the thiourea derivative, trovirdine. Table 2 lists the anti-HIV and SIA profiles of 18 phenyl ring-substituted thiourea compounds, in which one of the nitrogen atoms of the thiourea is attached to one of 16 different substituted phenyl rings (R 1 ) through an ethyl bridge, and the other nitrogen atom is attached to a 5Ј-bromo-or 5Ј-trifluoromethyl-substituted (R 2 ) pyridyl ring. Among the 16 substituted-phenylthiourea derivatives, functionalization of the phenyl ring with 2,5-dimethoxy (HI-236), 2-fluoro (HI-240), 3-fluoro (HI-241), and 2-chloro (HI-253) was associated with enhanced anti-HIV activity (IC 50[p24] ) ϭ Ͻ1 nM; IC 50 6.4 M. By comparison, the unsubstituted 5Ј-trifluoromethyl phenylthiourea (HI-308) was inactive, and its alkoxy-(HI-310) and halo-(HI-311) substituted derivatives were less potent (IC 50[p24] ) values of 0.08 and 0.09 M and IC 50[rRT] values of 2 and 0.6 M, respectively. Thus, the substitution of the phenyl ring with various functional groups had a major impact on the anti-HIV activity of unsubstituted parent compound (HI-275). Specifically, functionalization of 5-bromo pyridyl-substituted thiourea derivatives with alkoxy or halo substitutions on the phenyl ring led to superior anti-HIV activity. Exposure of the highly motile fraction of human sperm to 12 of the 18 substituted phenylthiourea derivatives listed in Table 2 did not affect sperm motility, even at concentrations as high as 500 M. Notably, halo-functionalized, phenyl-substituted thiourea derivatives with 2-fluoro (HI-240), 2-chloro (HI-253), and 4-chloro (HI-255) functional groups showed, in addition to their potent anti-HIV activity (IC 50[p24] ϭ Ͻ1 nM), also spermicidal activity, with EC 50 values of 147, 70, and 160 M, respectively (Table 2) . Thus, halo substitution of the phenyl ring was essential for the SIA of phenylthiourea compounds.
The SIA of these dual-function thiourea derivatives was not related to their partition coefficient values ( Table 2) . The spermicidal compounds HI-240, HI-253, HI-255, and HI-275 had low P a values (range, 1.04 to 3.50). The lack of a correlation between the P a values and the biological activity of phenyl-substituted thiourea derivatives demonstrates that these properties are not dependent on the lipophilicity of the compounds.
Anti-HIV and SIA of Heterocyclic Thiourea Compounds
Next, we synthesized a series of thiourea derivatives in which one of the nitrogen atoms of the thiourea is attached to one of five different heterocyclic substituents (R 1 ) through an ethyl bridge and the other nitrogen atom is attached to a 5-bromo or 5-trifluoromethyl substituted pyridyl ring. Table 3 lists the anti-HIV and SIA profiles of five heterocyclic ring-substituted thiourea derivatives with and without 5-bromo or 5-trifluoromethyl functionalization (R 2 ) on the pyridine ring. When compared with trovirdine (listed as HI-142), both the piperdil (HI-172) and piperazinyl (HI-258)-containing thiourea derivatives were more potent in inhibiting the replication of HIV-1 strain HTLV IIIB in human PBMC, with IC 50 values of Ͻ1 nM and 2 nM, respectively, but they lacked SIA (EC 50 values ϭ Ͼ 500 M). Among the eight heterocyclic thiourea derivatives tested, the 5-bromo-functionalized thioureas (HI-172, HI-258 and trovirdine) were more potent than trifluoromethyl-substituted (HI-309) or unsubstituted thioureas (HI-207). Unlike trovirdine, which lacked SIA, the unsubstituted pyridyl thiourea (HI-207) exhibited anti-HIV activity (IC 50[p24] ϭ 0.27 M), as well as SIA (EC 50 ϭ 279 M). In addition, the more lipophilic piperidinyl derivative of trifluoromethyl functionalized thiourea (HI-344) exhibited SIA (EC 50 ϭ 131 M), but it lacked anti-HIV activity (IC 50[rRT] ϭ Ͼ100 M; Table 3 ).
Anti-HIV and SIA of Alicyclic Thiourea Compounds
In addition to the compounds described above bearing phenyl and heterocyclic rings with and without 5Ј functionalization, we also examined the effect of alicyclic ringcontaining thiourea compounds. Table 4 lists the anti-HIV and SIA profiles of five alicyclic-substituted thiourea derivatives. Replacement of the pyridyl ring of trovirdine with a cis-myrtanyl (HI-444) resulted in loss of anti-HIV activity, whereas replacement with a cyclohexenyl ring did not. The unsubstituted cyclohexenyl ring-containing inhibitor (HI-541) lacked SIA (EC 50 ϭ Ͼ500 M). However, functionalization at the 5Ј-position of the pyridyl ring of cyclohexenyl ring-containing thioureas with a bromine or a chlorine atom led to a significant increase in anti-HIV activity as well as gain of spermicidal function. Cyclohexenyl ring-substituted thiourea derivatives with either 5-bromo (HI-346) or 5-chloro (HI-445) functionalization were the most potent dual-function agents, with IC 50[p24] values of 3 nM and EC 50 values of 42 M and 57 M, respectively. Both of these compounds also inhibited HIV-1 RT activity with IC 50 values of 0.6 M and 0.5 M, respectively. By comparison, the anti-HIV activity of the trifluoromethylsubstituted cyclohexenyl thiourea derivative (HI-347) was 26-fold less active, and its SIA was twofold to threefold less active than those of halo-functionalized thiourea derivatives. Thus, the potency order for SIA of cyclohexenyl substituted thiourea derivatives was as follows: bromo Ͼ chloro Ͼ trifluoromethyl. Spermicidal cyclohexenyl ringcontaining thiourea derivatives had higher P a values (6.3-11.5) than the inactive cis-myrtanyl-substituted (2.1) thiourea derivative (HI-444), suggesting that the biological activity of cyclohexenyl thiourea derivatives may in part be related to their increased lipophilicity. All three cyclohexenyl ring-containing thioureas with additional substitutions on the 5Ј-position of the pyridyl ring induced a concentration-dependent SIA. (Fig. 2) . The effective 100% inhibitory concentration (EC 100 ) was obtained at 0.25 mM for compounds HI-346 and HI-445 and at 1 mM for HI-347. The concentration-dependent sperm motility loss induced by cyclohexenyl-substituted thiourea derivatives was also associated with significant changes in the movement characteristics of the surviving sperm, particularly with respect to VCL, VAP, and VSL. The representative sperm kinematic parameters of cyclohexenyl-substituted, thiourea-treated sperm versus concentration is shown in Figure 3 . The decreases in VSL and VCL or VSL and VAP were similar in magnitude. Therefore, values for LIN of the sperm tracks and the STR of the swimming pattern remained relatively constant. Also, the BCF and the ALH were relatively stable as the proportion of motile sperm declined during the linear phase of motility loss. The sperm motion parameters of control sperm showed no significant changes (data not shown).
Selective Spermicidal Activity of Dual-Function Thiourea Compounds
In order to determine whether the observed SIA was due to nonspecific membrane damaging effect of dual-function thiourea derivatives, we tested the potential cytotoxicity of five most potent dual-function thiourea derivatives versus N-9 against confluent monolayers of normal human vaginal, ectocervical, and endocervical epithelial cells using the MTT assay. Cells were exposed to these compounds at concentrations ranging from 7.8 M to 1000 M for 3 h. The concentration-dependent cell survival curves for dual-function thiourea derivatives versus N-9 for these cells measured by the MTT assay were compared with the SIA measured by CASA (Table 5 ). In MTT assays, N-9 exhibited significant cytotoxicity to normal human vaginal, ectocervical and endocervical epithelial cells at spermicidal concentrations (EC 50 ϭ 81 M) with mean IC 50[MTT] values of 64 M (selectivity index [SI] ϭ 0.7), 58 M (SI ϭ 0.7), and 32 M (SI ϭ 0.3), respectively. By comparison, the IC 50[MTT] values for the most potent spermicidal dual-function thiourea derivatives against normal human vaginal, ectocervical, and endocervical epithelial cells were well above their spermicidal EC 50 values (SI range, Ͼ6.8 to Ͼ23.8). Thus, unlike N-9, which was spermicidal only at cytotoxic concentrations, dual-function spermicidal thiourea derivatives showed high selectivity indices against these cells. Thus, spermicidal dual-function thiourea derivatives were significantly less active against reproductivetract epithelial cells.
DISCUSSION
We identified several thiourea compounds as dual-function spermicidal agents with anti-HIV activity. Among the 30 novel thiourea derivatives that were rationally designed, synthesized, and evaluated for anti-HIV activity and SIA, the ortho-fluoro, ortho-chloro, and para-chloro-substituted phenyl ring-containing derivatives and cyclohexenyl ring-containing derivatives were the most potent dual-function agents. The molecular mechanism of the spermicidal activity exhibited by thiourea compounds is unknown. We previously reported that aryl phosphate derivatives of zidovudine with bromo-methoxy functionalization on the thymine ring also acquire potent SIA in addition to their potent anti-HIV activity [65] [66] [67] [68] [69] [70] . Because the ethyl linker and the bromo substitutions on the pyridyl ring are present in 21 of 31 thiourea derivatives investigated, the unique SIA of halo-substituted phenylthiourea derivatives is most likely due to their halo substituents in the phenyl ring. It was demonstrated that substituting ortho-fluoro group on the phenyl ring with a chloro group further enhanced the spermicidal potency of phenyl-substituted thiourea derivatives. Similarly, the unsubstituted cyclohexenyl ring-containing thiourea lacked SIA, whereas 5Ј functionalization on the pyridyl ring of the cyclohexenyl ring-substituted thiourea derivatives resulted in potent dual-function SIA irrespective of the 5Ј-substitutions on the pyridyl ring. The lack of SIA of unsubstituted cyclohexenyl ring-containing thiourea clearly demonstrated that in addition to the presence of a cyclohexenyl ring, further functionalization of the pyridyl ring is essential for the gain of spermicidal function, the potency of which can be modulated by various functional groups.
In order to determine whether the biological activities of the thiourea compounds vary with their lipophilicities, their partition coefficients between n-octanol and water were determined as an index of the rate of transfer of the molecule across the cell membrane and into the cell. The observed lack of a correlation between the P a values and the biological activity of phenyl-substituted thiourea derivatives suggests that the dual-function properties of phenyl-and heterocyclic-ring-substituted thiourea derivatives are not dependent on the partition coefficient of the molecule. On the other hand, the cyclohexenyl substitution enhances the lipophilic character that might contribute to an increased penetrability of cyclohexenyl ring-substituted thiourea derivatives through the plasma membrane of sperm.
The ectocervical epithelium and endocervical mucosa are highly susceptible to HIV-1 infection because of lesions or hormonal liquefaction and other changes that occur before, during, and after ovulation [14] [15] [16] [17] [18] . Our studies clearly demonstrated that unlike the detergent spermicide, N-9, the dual-function thiourea derivatives were selectively spermicidal when compared with N-9, which was cytotoxic to human vaginal, ectocervical, as well as endocervical epithelial cells at spermicidal concentrations. Thus, the cervicovaginal epithelial cells appear to be vulnerable to cytotoxic insults from the detergent-type spermicides. Therefore, the dual-action spermicidal thiourea derivatives that do not elicit any detergent-type membrane toxicity may offer significant clinical advantages. The lack or reduced toxicity of spermicidal thiourea derivatives to human vaginal, ectocervical, and endocervical epithelial cells when compared with N-9 warrant the further development of these dual-action compounds as a new class of vaginal contraceptives. In the acidic environment of the vagina, these spermicidal thiourea compounds would be stable as protonated species because of the presence of a pyridine ring with a basic nitrogen atom. On the basis of the lack or reduced cytotoxicity of these spermicidal thioureas, we believe that the dual-function thiourea compounds, when administered intravaginally, will not have adverse systemic side effects. Future preclinical studies will carefully examine the effects of intravaginally applied dual-function thiourea compounds on the short-term and long-term safety and reproductive health of test animal species.
The synthesis of novel thiourea compounds as dual-function anti-HIV agents with spermicidal function represents a significant step forward in the development of new microbicides for curbing heterosexual HIV transmission. In addition to their potent anti-HIV activity against the wild-type RT, compounds HI-346 and HI-445 exhibited potent antiviral activity against NNI-resistant as well as multidrugresistant strains of HIV-1 [52, 57] . Virucidal spermicides that are also active against NNI-resistant and multidrug resistant strains of HIV-1 will be a tremendous advantage for the development of broad-spectrum microbicides because a high percentage of newly infected individuals in the United States harbor NNI-resistant mutants. The promising results reported herein illustrate that dual-function NNIs, particularly HI-253, HI-346, and HI-445, show unique clinical potential to become the active ingredients of new, femalecontrolled, topical virucidal vaginal contraceptives for women who are at high risk for acquiring HIV by heterosexual transmission. The further development of these dualfunction NNIs as novel vaginal virucidal spermicides may provide the basis for a new strategy aimed at prevention of the sexual transmission of HIV while providing effective fertility control for women.
